Connecticut Certification Board

Scope of Practice

Connecticut Certification Board

  • "Rehab Doesn't Do Anything..."

"Rehab Doesn't Do Anything..."

Tuesday 24th August 2021

Dr. Mark Willenbring critiques traditional rehab models and advocates for evidence-based, individualized addiction treatment on 'Scope of Practice'.
64 minutes
Informative
Thought-provoking
Raw
Engaging
Transformative

About this podcast

Scope of Practice
Author:
Connecticut Certification Board
Overview:
Categories:
Sobriety Toolkit
Innovative Treatments & Recovery Paths
Family Recovery from Addiction
Recovery from Trauma
Navigating Intimate Relationships
Links:
Visit site
Episodes:
91 (View all)
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Rethinking Rehab: Dr. Mark Willenbring's Take on Modern Addiction Treatment

The current addiction treatment system is not built on science but on an antiquated rehab model that has not changed once since. Whether you agree or disagree, you'll want to listen!
What if the traditional rehab model isn't as effective as we think? In this eye-opening episode, Dr. Mark Willenbring, former Director of Treatment and Recovery Research at NIAAA and CEO of Alltyr, pulls no punches in his critique of the current Substance Use Disorder (SUD) treatment system. He argues that the rehab model, largely unchanged since its inception, lacks a solid evidence base and fails to deliver meaningful outcomes for many. Dr.
Willenbring sheds light on the first week's focus on physical detox, followed by an over-reliance on Alcoholics Anonymous (AA) in subsequent weeks, which he believes is far from a transformative solution. Instead, he advocates for a more individualized approach, where each person's journey to sobriety is unique and should be treated as such. He also touches on the need for higher professionalism within the field and the importance of a respectful and effective comprehensive care system.
Highlighting alternative treatments like cognitive-behavioral therapy and medications such as Naltrexone and Gabapentin, Dr. Willenbring challenges the one-size-fits-all mentality that pervades current practices. This episode is a must-listen for anyone interested in understanding the complexities of addiction recovery and seeking more effective treatment options.